BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15864887)

  • 21. Oxaliplatin-related hyperammonaemic encephalopathy in a patient with colon cancer.
    Chang YY; Lin JK; Jiang JK
    Colorectal Dis; 2012 Dec; 14(12):e821. PubMed ID: 22330089
    [No Abstract]   [Full Text] [Related]  

  • 22. Anaphylactic reaction to oxaliplatin: a case report.
    Larzillière I; Brandissou S; Breton P; Lingoungou A; Gargot D; Ramain JP; Harnois C
    Am J Gastroenterol; 1999 Nov; 94(11):3387-8. PubMed ID: 10566767
    [No Abstract]   [Full Text] [Related]  

  • 23. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions.
    Zhang X; Zhao Y; Zheng Y; Dong Y
    J Investig Allergol Clin Immunol; 2017; 27(1):65-66. PubMed ID: 28211349
    [No Abstract]   [Full Text] [Related]  

  • 24. Sudden-onset thrombocytopenia with oxaliplatin.
    Dold FG; Mitchell EP
    Ann Intern Med; 2003 Jul; 139(2):E156. PubMed ID: 12859182
    [No Abstract]   [Full Text] [Related]  

  • 25. Anaphylaxis after oxaliplatin.
    Médioni J; Coulon MA; Morere JF; Hennebelle F; Piperno-Neumann S; Breau JL
    Ann Oncol; 1999 May; 10(5):610. PubMed ID: 10416017
    [No Abstract]   [Full Text] [Related]  

  • 26. Midventricular Takotsubo cardiomyopathy after oxaliplatin infusion: an unreported side effect.
    Coli S; Pigazzani F; Gaibazzi N
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):646-9. PubMed ID: 25333375
    [No Abstract]   [Full Text] [Related]  

  • 27. [Genetic backgrounds of peripheral neuropathy induced by oxaliplatin].
    Mitsuma A; Ando Y
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):62-5. PubMed ID: 23391543
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful desensitization to oxaliplatin.
    Mis L; Fernando NH; Hurwitz HI; Morse MA
    Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Readministration of oxaliplatin using a rapid desensitization method after severe anaphylactic reaction].
    Arotçarena R; Berthélémy P; Piot M; Pariente A
    Gastroenterol Clin Biol; 2001 Feb; 25(2):206-7. PubMed ID: 11319450
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxaliplatin-induced proximal renal tubular acidosis.
    Negro A; Grasselli C; Galli P
    Intern Emerg Med; 2010 Jun; 5(3):267-8. PubMed ID: 19937480
    [No Abstract]   [Full Text] [Related]  

  • 31. Radiation recall with oxaliplatin: report of a case and a review of the literature.
    Chan RT; Au GK; Ho JW; Chu KW
    Clin Oncol (R Coll Radiol); 2001; 13(1):55-7. PubMed ID: 11292139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case report of oxaliplatin extravasation.
    Foo KF; Michael M; Toner G; Zalcberg J
    Ann Oncol; 2003 Jun; 14(6):961-2. PubMed ID: 12796037
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.
    Lehky TJ; Leonard GD; Wilson RH; Grem JL; Floeter MK
    Muscle Nerve; 2004 Mar; 29(3):387-92. PubMed ID: 14981738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.
    Baker DE
    Rev Gastroenterol Disord; 2003; 3(1):31-8. PubMed ID: 12684591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute, generalised but transient muscle cramping and weakness shortly after first oxaliplatin infusion.
    Krexner E; Stickler A; Prainer C; Finsterer J
    Med Oncol; 2012 Dec; 29(5):3592-3. PubMed ID: 22669568
    [No Abstract]   [Full Text] [Related]  

  • 36. Review of hypersensitivity reactions to antineoplastic agents.
    Cortijo-Cascajares S; Jiménez-Cerezo MJ; Herreros de Tejada A
    Farm Hosp; 2012; 36(3):148-58. PubMed ID: 22484106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
    Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of hypersensitivity reactions caused by oxaliplatin.
    Herrero T; Tornero P; Infante S; Fuentes V; Sánchez MN; De Barrio M; Baeza ML
    J Investig Allergol Clin Immunol; 2006; 16(5):327-30. PubMed ID: 17039675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
    Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
    Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.